Results 111 to 120 of about 37,023 (237)

Treatment‐Related Adverse Events and Health‐Related Quality of Life Associated With Immune Checkpoint Inhibitor Treatment for Mucosal Head and Neck Squamous Cell Carcinoma: A Scoping Review

open access: yesHead &Neck, Volume 48, Issue 11, Page 3152-3172, November 2026.
ABSTRACT Background Supportive care needs of patients receiving immune checkpoint inhibitors (ICIs) for head and neck squamous cell carcinoma (HNSCC) are ill‐defined. Hence, known treatment‐related adverse events (TRAEs) and health‐related quality of life (HRQoL) associated with ICI treatment for HNSCC were examined to inform future supportive care ...
N. D. O'Donnell   +11 more
wiley   +1 more source

Benefits of ginger in the control of chemotherapy-induced nausea and vomiting

open access: yesRevista Brasileira de Enfermagem
Objectives: To identify and discuss scientific evidence of the effects of ginger use on the management of chemotherapy-induced nausea and vomiting. Methods: This is an integrative reviewperformed by Ganong’s reference.
Dayane Oliveira Borges   +3 more
doaj   +1 more source

Management of advanced mycosis fungoides and Sézary Syndrome: International Recommendations for systemic treatments and allogeneic hematopoietic cell transplantation from the European Hematology Association, the EORTC Cutaneous Lymphoma Tumours Group, the International Society for Cutaneous Lymphoma, and the Lymphoma Working Party of the EBMT

open access: yesHemaSphere, Volume 10, Issue 11, November 2026.
Abstract Advanced mycosis fungoides (MF) and Sézary syndrome (SS) are the most aggressive forms of cutaneous T‐cell lymphoma and remain associated with a poor prognosis and heterogeneous therapeutic approaches. Recent advances, including targeted therapies and improved transplant strategies, have substantially expanded treatment options, highlighting ...
Francesco Onida   +29 more
wiley   +1 more source

The Combined Value of the Prognostic Nutritional Index and Pan‐Immune‐Inflammation Value in Predicting Neoadjuvant Chemotherapy and Survival in Locally Advanced Colon Cancer: A Retrospective Study

open access: yesImmunity, Inflammation and Disease, Volume 14, Issue 11, November 2026.
ABSTRACT Background The pan‐immune inflammation value (PIV) and prognostic nutritional index (PNI) are established markers of systemic inflammatory/immune status and nutritional status, respectively. The potential synergistic effect of combining these indices remains unexplored. This study aimed to evaluate the utility of a novel combined PIV‐PNI score
Zihao Chen   +5 more
wiley   +1 more source

Chemotherapy-induced nausea and vomiting: a review to inform clinical practice

open access: yes, 2013
Chemotherapy-induced nausea and vomiting: a review to inform clinical ...
Alexandra McCarthy (3804586)   +7 more
core   +1 more source

Discrepant Urinary Findings Between Dipstick Protein and Sulfosalicylic Acid Test in a Patient With Hyaline Casts: A Case Report

open access: yesJournal of Clinical Laboratory Analysis, Volume 40, Issue 21, November 2026.
In this post‐transplant patient, increased hyaline casts with negative dipstick protein but positive SSA testing occurred during evolving acute kidney injury and resolved with renal recovery. This discordant urinalysis pattern may warrant confirmatory protein testing and correlation with serial renal function in patients at high risk of AKI.
Yifei Jia   +6 more
wiley   +1 more source

Ruta graveolens L. in Evidence‐Based Phytotherapy: Pharmacological Activities, Bioactive Compounds and Safety

open access: yesPhytotherapy Research, Volume 40, Issue 11, Page 6320-6369, November 2026.
Graphical representation of ethnomedical uses, major bioactive compounds, pharmacological potential and toxicological risks of Ruta graveolens L. ABSTRACT Ruta graveolens L. is widely used in traditional European, Asian, African, and South American medicine for digestive, nervous, cardiovascular, respiratory, and reproductive disorders.
Tetiana Serhiienko   +3 more
wiley   +1 more source

Efficacy and safety of ondansetron orally soluble pellicle for preventing moderate- to high-emetic risk chemotherapy-induced nausea and vomiting

open access: yesBMC Cancer
Objective Ondansetron orally soluble pellicle can serve as an alternative option for preventing nausea and vomiting in patients who receive chemotherapy. However, there is a lack of clinical evidence regarding ondansetron. This study aimed to explore the
Lu Sun   +10 more
doaj   +1 more source

Effectiveness of foot massage on chemotherapy-induced nausea and vomiting, fatigue, and quality of life among cancer patients: A non-equivalent control group design

open access: yesJournal of Education and Health Promotion
BACKGROUND: Cancer remains a major global health issue. Chemotherapy often leads to nausea, vomiting, and fatigue, adversely affecting patients’ quality of life.
Jenefa Jesu Nesam Kamaraj   +2 more
doaj   +1 more source

Theories of self-care: their relevance to chemotherapy-induced nausea and vomiting

open access: yes, 1991
Nausea and vomiting are reputed to be two of the most disruptive side-effects associated with chemotherapy Pharmacological and behavioural interventions are well described in the literature, but sparse attention appears to have been focused upon the role
Alison Richardson, Richardson, Alison
core   +1 more source

Home - About - Disclaimer - Privacy